Overview

From diffuse gliomas and meningiomas to embryonal neoplasms and sellar region tumors - this clinical atlas maps the full landscape of modern CNS tumor diagnosis, molecular profiling, and therapeutic decision-making in a single, organized volume.Atlas of Central Nervous System Tumour Classification delivers a systematic, evidence-based approach to brain and spinal cord neoplasm evaluation. Each tumor entity is presented through a consistent framework: histopathological features, immunohistochemical profiles, molecular markers, WHO-aligned grading parameters, and current treatment strategies - connecting tissue-level findings to bedside decisions in a format built for daily diagnostic and clinical practice. The organizational approach moves from pathophysiology through pattern recognition to therapeutic reasoning, building the reader's understanding of each entity rather than simply listing facts. More than 100 clinical procedure and teaching videos accessible through integrated QR codes bring microscopic findings, staining patterns, and diagnostic workflows to life beyond the printed page. Clinical images and illustrations throughout the text support visual learning and reinforce the morphological and molecular features that drive accurate classification. What distinguishes this atlas from condensed pocket references and sprawling multi-volume texts is its integration of depth with accessibility - current molecular diagnostics alongside practical histopathological criteria, all organized for efficient use during sign-out, tumor board preparation, and clinical decision-making. Diffuse gliomas: astrocytomas, oligodendrogliomas, and pediatric-type diffuse gliomas with IDH, 1p/19q, and histone mutation integration Embryonal tumors: medulloblastoma molecular subgroups, AT/RT, and other CNS embryonal neoplasms with risk stratification Meningeal and mesenchymal tumors: meningioma grading, solitary fibrous tumor, melanocytic lesions, and hemangioblastoma Sellar region and cranial nerve tumors: pituitary neuroendocrine tumors, craniopharyngiomas, and schwannomas CNS lymphomas and histiocytic neoplasms: diagnostic workup, immunophenotyping, and treatment approaches Molecular biomarker integration: IDH mutations, MGMT promoter methylation, BRAF alterations, CDKN2A/B deletions, and other actionable markers WHO-aligned nomenclature and grading: current classification standards applied consistently across all tumor entities Therapeutic pathways: surgical, radiation, systemic, and targeted therapy considerations organized by tumor type Designed for pathologists, neuropathologists, neuro-oncologists, neurosurgeons, neurology residents, and oncology fellows, this atlas also serves trainees preparing for board examinations in neuropathology and neuro-oncology. Whether used at the microscope, in the clinic, or during exam review, it provides the integrated diagnostic and management framework that modern CNS tumor care demands. Bring current, visually integrated CNS tumor expertise to your practice - scroll up and order your copy today.

Full Product Details

9798197227126

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available